Medplus announces a seven-day suspension of a drug license at a store in Andhra Pradesh by its subsidiary Optival Health Solutions, potentially impacting revenue by about ₹3.82 lakh; disclosure filed with BSE/NSE on 11 November 2025.
AI Assistant
Medplus Health Services Ltd
2025
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.